Management of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the Era of Targeted Therapies

被引：0
|
作者：
Michael Rainone
Tanya Siddiqi
机构：
[1] City of Hope,Department of Hematology and Medical Oncology
[2] City of Hope,Department of Hematology & Hematopoietic Cell Transplantation
来源：
Current Hematologic Malignancy Reports | 2022年 / 17卷
关键词：
Chronic lymphocytic leukemia; Small lymphocytic lymphoma; Ibrutinib; Acalabrutinib; Venetoclax; Chimeric antigen receptor (CAR) T cell;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：39 / 45
页数：6
相关论文
共 50 条
  • [21] Indirect comparisons of efficacy of zanubrutinib versus orelabrutinib in patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma or relapsed or refractory mantle cell lymphoma
    Yuqin Song
    Keshu Zhou
    Shenmiao Yang
    Jianda Hu
    Dehui Zou
    Sujun Gao
    Ling Pan
    Tingyu Wang
    Haiyan Yang
    Huilai Zhang
    Daobin Zhou
    Jie Ji
    Wei Xu
    Ru Feng
    Jie Jin
    Fangfang Lv
    Haiwen Huang
    Xiaosi Fan
    Sheng Xu
    Jun Zhu
    Investigational New Drugs, 2023, 41 : 606 - 616
  • [22] "Accelerated" Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Clinicopathologic Features and Survival Characteristics in the Era of Novel Therapies
    Vadasz, Brian
    Zak, Taylor
    Pearson, Erik
    Sukhanova, Madina
    Gao, Juehua
    Chen, Yi-Hua
    Chen, Qing
    Tariq, Hamza
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1492 - S1493
  • [23] Zanubrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final results and correlative analysis of lymphocytosis
    Xu, Wei
    Yang, Shenmiao
    Zhou, Keshu
    Pan, Ling
    Li, Zengjun
    Gao, Sujun
    Zhou, Daobin
    Hu, Jianda
    Feng, Ru
    Huang, Haiwen
    Wang, Tingyu
    Li, Dengju
    Ji, Meng
    Guo, Haiyi
    Zhao, Xia
    Wu, Binghao
    Yu, Yiling
    Wang, Yu
    Huang, Jane
    Novotny, William
    Li, Jianyong
    LEUKEMIA & LYMPHOMA, 2023, 64 (03) : 712 - 716
  • [24] Zanubrutinib Monotherapy for Naive and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Pooled Analysis of Three Studies
    Xu, Wei
    Yang, Shenmiao
    Tam, Constantine S.
    Seymour, John F.
    Zhou, Keshu
    Opat, Stephen
    Qiu, Lugui
    Sun, Mingyuan
    Wang, Tingyu
    Trotman, Judith
    Pan, Ling
    Gao, Sujun
    Zhou, Jianfeng
    Zhou, Daobin
    Zhu, Jun
    Song, Yuqin
    Hu, Jianda
    Feng, Ru
    Huang, Haiwen
    Su, Dan
    Shi, Miao
    Li, Jianyong
    ADVANCES IN THERAPY, 2022, 39 (09) : 4250 - 4265
  • [25] Healthcare Resource Utilization and Costs of Relapsed or Refractory Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Treated with Ibrutinib
    Yang, Xiaoqin
    Zanardo, Enrico
    Lejeune, Dominique
    De Nigris, Enrico
    Sarpong, Eric
    Farooqui, Mohammed Z. H.
    Laliberte, Francois
    BLOOD, 2022, 140 : 10911 - 10912
  • [26] The Treatment of Relapsed Refractory Chronic Lymphocytic Leukemia
    Brown, Jennifer R.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2011, : 110 - 118
  • [27] Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia
    Veliz, Marays
    Pinilla-Ibarz, Javier
    CANCER CONTROL, 2012, 19 (01) : 37 - 53
  • [28] Pharmacotherapy of relapsed/refractory chronic lymphocytic leukemia
    Abou Zahr, Abdallah
    Bose, Prithviraj
    Keating, Michael J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (09) : 857 - 873
  • [29] Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
    Odetola, Oluwatobi
    Ma, Shuo
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2023, 18 (05) : 130 - 143
  • [30] Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
    Oluwatobi Odetola
    Shuo Ma
    Current Hematologic Malignancy Reports, 2023, 18 : 130 - 143
12345